Feng Wang

Dr. Feng Wang

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
LHLiangchang Hu
Liangchang Hu
PWPing Wang
Ping Wang
RZRunan Zhao
Runan Zhao
SLShanshan Li
Shanshan Li
FWFeng Wang
Feng Wang
SWShian Wu
Shian Wu

1 December 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
ZCZhi Cheng
Zhi Cheng
YZYuling Zhang
Yuling Zhang
FWFeng Wang
Feng Wang
Background: Circular RNA represents a distinctive form of noncoding RNA resulting from back‐splicing of exons and introns in mRNA. CircRNA has been shown play important roles in neurological diseases, such as Alzheimer’s disease (AD). Some recent studies also have demonstrated circRNA is enriched in the mammal brain and differentially altered during AD. However, little is known the characteristics and functions of key circRNAs directly linked to cognitive of AD. Herein, we identified circDENND1B as a novel circRNA implicated in AD and elucidated its role in cognitive impairment.Methods: We generated rRNA and linear RNA depleted, and RNA sequencing data from 12‐month‐old 5 × FAD mice hippocampus. The circDENND1B knockdown nanoparticles were applied in 10‐month‐old 5 × FAD mice. The novel object recognition and Morris water maze tests were used to observe cognitive function in these 12‐month‐old mice, and conducting electrophysiological experiments, Golgi‐Cox staining, and measuring blood‐brain barrier permeability improvement also performed in the 5 × FAD mice after circDENND1B knockdown. The fluorescence staining, RNA in situ hybridization, RNA antisense purification, RNA pull‐down, RT‐qPCR, Western blot were quantify the functions of circDENND1B in mice brain and vitro human BBB model.Results: CircDENND1B, a circRNA enriched in hippocampal neurons, was significantly up‐regulated in AD mice and patients. Knockdown of circDENND1B markedly improved cognitive dysfunctions associated with AD. Additionally we revealed that miR‐17‐5p served as a crucial downstream mediator of circDENND1B‐regulated Blood‐brain barrier (BBB) permeability. Notably, key targets of miR‐17‐5p included lncKCNQ1OT1/VegfA, which involved in the regulation of BBB as well as learning and memory. Overexpression of miR‐17‐5p altered circDENND1B and lncKCNQ1OT1 transcellular shuttling, thereby regulating VegfA expression in brain microvascular endothelial cells leading to changes in BBB permeability.Conclusion: In conclusion, we demonstrated elevated circDENND1B levels in AD patients and provided evidence that the circDENND1B/lncRNA KCNQ1OT1/miR‐17‐5p/VegfA transcellular regulatory axis plays a role in regulating BBB permeability and neuron inflammatory response in both in vivo and in vitro AD models. This identified that circDENND1B/lncRNA KCNQ1OT1/miR‐17‐5p/VegfA transcellular regulatory axis may serve as a novel biomarker for AD, offering new insights for prediction, prognosis, and treatment of AD patients.

13 February 2026 in Discover Oncology
Verified
Journal Article
Open access
PDF file
DYDuo Yun
Duo Yun
QMQier Mu
Qier Mu
YLYanli Li
Yanli Li
WWWenpeng Wang
Wenpeng Wang
RARiwen An
Riwen An
FWFeng Wang
Feng Wang
LGALS3BP, a multifunctional glycoprotein, is highly expressed in human cancers and associated with poor clinical outcomes. However, there is a lack of comprehensive analysis across multiple cancer types.This study utilized RNA sequencing, TMB, MSI, and clinical data from TCGA and clinical profiles, covering 33 cancer types. The expression of LGALS3BP was analyzed and pan-cancer mutation information was obtained from cBioPortal. Tumor microenvironment analysis employed the “ESTIMATE” and CIBERSORT algorithms. Single-cell analysis was performed using the TISCH2 database. protein–protein interactions and functional enrichment analysis utilized the STRING database. LGALS3BP expression varied in different tumor types, being higher in BLCA, BRCA, ESCA, GBM, HNSC, KIRC, LUAD, and UCEC. It was associated with prognosis, with higher levels indicating worse survival in some cancers. LGALS3BP also affects TMB, MSI, tumor immune infiltration and the presence of specific immune cell populations. It interacted with immune stimulators, MHCs, and immune inhibitors. Single-cell analyses showed the elevated expression in certain cell types, and protein–protein interaction analysis revealed its involvement in immune response and tumor microenvironment. LGALS3BP expression is associated with patient outcomes and tumor immune response in various cancer types, highlighting its potential as a prognostic marker. However, additional experimental validation is needed to confirm these findings.

1 December 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
FWFeng Wang
Feng Wang
YLYangping Li
Yangping Li
HSHuifeng Shen
Huifeng Shen
YFYue Feng
Yue Feng
BYBing Yao
Bing Yao
Background: Circular RNAs (circRNAs) play multifaceted roles to precisely control expression of broad gene networks. These highly stable molecules are often accumulated in the mammalian brain and thought to serve as “memory molecules” that govern the long process of aging. Mounting evidence demonstrated circRNA dysregulation in the postmortem brains of Alzheimer’s disease (AD). However, whether and how circRNAs dysregulation underlies AD disease progression remain unexplored.Methods: Poly(A)‐tailing/RNase R digestion was coupled with a recently published computational algorithm called CARP to examine circRNA landscapes alteration and identify functional circRNA‐pathways progressively dysregulated in the cerebral cortex of the 5xFAD mouse model of AD between 5‐ and 7‐month, a critical window for the transition of starting pathology to full manifestation. We have also employed comprehensive biochemical approaches to identify circRNA interactome, as well as short hairpin RNA‐based genetic approaches to manipulate circRNAs and their key regulators to pinpoint their mechanistic contributions to AD.Results: We discovered genome‐wide alterations of brain circRNAs within the above age window critical for AD progression. Further analysis revealed co‐operation of distinct circRNAs and age‐dependent switch of circRNA isoforms derived from internal alternative splicing and alternative back splicing, which offered new means for regulating miRNA‐mRNA pathways in the 5xFAD cortex. In particular, we focused on conserved circRNAs that were progressively downregulated with increased severity of dementia in human AD brains. During circRNA biogenesis, we identified several previously established AD‐affected splicing factors, such as hnRNPL, regulate the production of AD‐associated circRNAs. Mechanistically, we found these circRNAs contained binding sites for many miRNAs and demonstrated its activity in sponging several AD‐relevant miRNAs to regulate their target mRNAs indicated in AD pathogenesis. Furthermore, we identified multiple circRNA‐interacting RNA binding proteins associated with AD, including the cleavage and polyadenylation factor 6 (CPSF6). In fact, altered polyadenylation efficiency was observed, which results in aberrant upregulation of many known CPSF6 target mRNAs indicated in AD pathogenesis.Conclusions: Together, our results unveiled pathological brain circRNA landscape alterations within a critical window for phenotypic progression in a mouse model of AD and identified novel molecular mechanisms underlying dysregulation of conserved circRNA pathways that contribute to AD pathogenesis.